Northern Netherlands Region grant for Prof. Quax
Prof. Wim Quax from the Groningen Research Institute of Pharmacy (GRIP) has received a grant worth EUR 200,000 from the Northern Netherlands Region (Samenwerkingsverband Noord-Nederland). Prof. Quax receives this grant for his project ‘Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2’. With this project, he aims to investigate a possible treatment of corona with hesperidin.
This flavonoid has been suggested to block the connection between the SARS-CoV-2 virus and the ACE2 receptor of human cells. The group of Prof. Quax will analyze how hesperidin reduces the affinity of the spike protein for its target, the ACE2 receptor. Hesperidin is a cheap by-product of citrus fruits and has been used safely in humans for years. Together with project partner Color&Brain, alternative delivery routes and their effects on virus binding will be investigated.
| Last modified: | 01 July 2020 1.31 p.m. |
More news
-
03 July 2025
Erik Heeres receives RUG Impact Innovator Excellence Award
During the RUG Ventures Innovation Day, Prof. Erik Heeres of the Faculty of Science and Engineering (RUG) was awarded the Impact Innovator Excellence Award.
-
02 July 2025
€ 30 million investment for UG spin-off Portal Biotech
Portal Biotech, a pioneer in nanopore-based protein identification and sequencing technology, has raised € 30 million in Series A funding. The funding will support commercial rollout and team growth.
-
01 July 2025
‘Give seals space’
The Wadden Sea is constantly changing. Native animals need to be able to adapt in order to thrive in an environment that is shaped by the tides. By conducting research on seals in the area, PhD students Margarita Méndez-Aróstegui and Beatriz...